APOE and Alzheimer disease: Beyond APOE, recent meta-analyses combining genome-wide association studies (GWAS) have expanded the number of AD-risk loci (Novikova et al., 2021), but most of the disease-associated variants reside in non-protein coding regions of the genome, making it difficult to elucidate how they affect AD susceptibility and pathogenesis.